- $6.67bn
- $6.30bn
- $3.73bn
- 95
- 29
- 90
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,037 | 2,403 | 2,627 | 3,025 | 3,729 |
Cost of Revenue | |||||
Gross Profit | 416 | 550 | 622 | 688 | 809 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,907 | 2,179 | 2,367 | 2,729 | 3,474 |
Operating Profit | 129 | 223 | 260 | 297 | 255 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 116 | 218 | 258 | 289 | 273 |
Provision for Income Taxes | |||||
Net Income After Taxes | 92.2 | 171 | 198 | 225 | 210 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 111 | 170 | 195 | 225 | 209 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 111 | 170 | 195 | 225 | 209 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.67 | 3.07 | 3.48 | 3.97 | 4.48 |
Dividends per Share |